Abstract
Objective Central hypothyroidism (CH) is a well-known adverse effect of bexarotene treatment for cutaneous T-cell lymphoma (CTCL). While concomitant l......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
